Valuation: Shockwave Medical

Market Cap 12.57B 11.04B 10.27B 9.42B 17.7B 1,210B 17.97B 122B 47.62B 595B 47.18B 46.16B 2,057B P/E 2025 *
-
P/E 2026 * -
Enterprise Value 12.35B 10.85B 10.09B 9.25B 17.39B 1,189B 17.66B 120B 46.79B 585B 46.35B 45.35B 2,021B EV / Sales 2025 *
-
EV / Sales 2026 * -
Free-Float
-
Yield 2025 *
-
Yield 2026 * -
1 day-0.01%
1 week+0.01%
Current month+0.01%
1 month+0.01%
3 months+0.01%
6 months+0.01%
Current year+0.01%
3 years 157
Extreme 157
334.9
5 years 113.36
Extreme 113.36
334.9
10 years 22.01
Extreme 22.01
334.9
Manager TitleAgeSince
Director of Finance/CFO 48 31/05/2024
President 51 01/11/2018
Chief Tech/Sci/R&D Officer 58 -
Director TitleAgeSince
Director/Board Member - 31/05/2024
Director/Board Member - 31/05/2024
Director/Board Member - 31/05/2024
Date Insider Type Main position Quantity % Market Cap.
31/05/24
Sofinnova Partners SAS
Issuer saleCompany 34,177 0.0911%
31/05/24 Issuer sale

Director

321,295 0.8569%
31/05/24 Issuer sale

Director

1,733 0.0046%
Change 5-day change 1-year change 3-year change Capi.($)
-0.01%+0.01%+0.01%+24.71% 12.57B
+0.26%+0.13%+38.47%+5.31% 12.54B
+0.52%-0.95%+14.98%+20.01% 6.47B
-0.53%-5.32%+42.66%+19.08% 5.48B
+3.06%-0.59% - - 4.73B
-3.39%+1.63%-27.77%+18.23% 4.32B
-2.85%-2.49%-25.95%-24.17% 3.92B
-11.71%+10.87%+40.75%-53.95% 2.06B
-0.34%-4.23%-12.63%+204.03% 1.72B
+0.33%+0.33%+56.28%-2.70% 1.55B
Average -1.47%-0.98%+14.09%+23.39% 5.53B
Weighted average by Cap. -0.58%-1.13%+14.63%+16.41%

Financials

2025 *2026 *
Net sales - -
Net income - -
Net Debt - -
Logo Shockwave Medical
Shockwave Medical, Inc. is a medical device company. The Company is primarily engaged in the development and commercialization of novel technologies that transform the care of patients with cardiovascular disease. The Company is focused on its intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular and heart valve disease. Built on a balloon catheter platform, the IVL technology uses lithotripsy to disrupt both superficial and deep vascular calcium., while minimizing soft tissue injury, and an integrated angioplasty balloon to dilate blockages at low pressures, restoring blood flow. Its Shockwave M5 IVL catheter and Shockwave M5+ IVL catheter are five-emitter catheters for use in its IVL System in medium-diameter vessels for the treatment of peripheral artery disease (PAD). Its Shockwave S4 IVL catheter is a four-emitter catheter for use in its IVL System in small-diameter vessels for the treatment of PAD.
Employees
1,468
  1. Stock Market
  2. Stocks
  3. SWAV Stock